Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Devin M, Enhoffer"'
Autor:
Eric T, Wittbrodt, James M, Eudicone, Kelly F, Bell, Devin M, Enhoffer, Keith, Latham, Jennifer B, Green
Publikováno v:
The American journal of managed care. 25(4)
The authors of the manuscript "Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population" respond to a letter to the editor.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e48bb9ac3c210ac2eb1edffab32ccb05
https://pubmed.ncbi.nlm.nih.gov/30986012
https://pubmed.ncbi.nlm.nih.gov/30986012
Autor:
Eric T, Wittbrodt, James M, Eudicone, Kelly F, Bell, Devin M, Enhoffer, Keith, Latham, Jennifer B, Green
Publikováno v:
The American journal of managed care. 24
Cardiovascular outcomes trials (CVOTs) for evaluating the safety of novel antidiabetic agents are required by the FDA. CVOTs vary in their design and inclusion criteria, making it difficult to evaluate their applicability to the general population. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80f3f54238d514486e5ef86029db4e5b
https://pubmed.ncbi.nlm.nih.gov/30986013
https://pubmed.ncbi.nlm.nih.gov/30986013
Autor:
Eric T, Wittbrodt, James M, Eudicone, Kelly F, Bell, Devin M, Enhoffer, Keith, Latham, Jennifer B, Green
Publikováno v:
The American journal of managed care. 24
Guidance to industry from the FDA requires studies to evaluate the cardiovascular safety of novel type 2 diabetes (T2D) medications. Although the objectives of such cardiovascular outcomes trials (CVOTs) are similar, differences in features such as e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b7b47559786277b6bb76beb8a1a305bc
https://pubmed.ncbi.nlm.nih.gov/29693360
https://pubmed.ncbi.nlm.nih.gov/29693360